A timely, in depth, evidence-based review of biosafety practices for those at risk for coronavirus (COVID-19) infection.

Chien-Chin Chen, Chia-Yu Chi

Overview

This commentary focuses on the cytopathology laboratory, the authors' experiences with coronavirus (COVID-19) in Taiwan, and current guidelines on COVID?19 infection prevention and control. The objective of this report is to provide cytopathology professionals a timely, in?depth, evidence-based review of biosafety practices for those at risk for coronavirus (COVID-19) infection.

Summary

Laboratory biosafety, including administrative strategies and containment principles, practices, and procedures, is an important aspect of this. Following guidelines recommended by the WHO, US CDC, and the European Center for Disease Prevention and Control, as described above, our cytology laboratories in Taiwan, along with other laboratories around the world, are using a strategy that is crucial for the prevention of COVID-19 infection by our health care professionals and their families.

Altmetric Statistics

Author Comments

Dr. Chien-Chin Chen, MD. MSc. FIAC
Dr. Chien-Chin Chen, MD. MSc. FIAC
Ditmanson Medical Foundation Chia-Yi Christian Hospital
Professor
Cytopathology and oncology
Chiayi city, Chiayi | Taiwan
While confronting the global spread of COVID-19, the effectiveness of the health system is critical for building public trust and ultimately eliminating infection.Dr. Chien-Chin Chen, MD. MSc. FIAC

Resources

https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncy.22280
https://acsjournals.onlinelibrary.wiley.com/doi/10.1002/cncy.22280

Biosafety in the preparation and processing of cytology specimens with potential coronavirus (COVID-19) infection: Perspectives from Taiwan.

Authors:
Dr. Chien-Chin Chen, MD. MSc. FIAC
Dr. Chien-Chin Chen, MD. MSc. FIAC
Ditmanson Medical Foundation Chia-Yi Christian Hospital
Professor
Cytopathology and oncology
Chiayi city, Chiayi | Taiwan

Cancer Cytopathol 2020 05 7;128(5):309-316. Epub 2020 Apr 7.

National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli, Taiwan.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.22280DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262216PMC
May 2020
3.354 Impact Factor

Publication Analysis

Top Keywords

coronavirus covid-19
4
potential coronavirus
4
covid-19 infection
4
infection perspectives
4
perspectives taiwan
4
cytology specimens
4
specimens potential
4
preparation processing
4
biosafety preparation
4
processing cytology
4
perspectives
1
processing
1
taiwan
1
infection
1
cytology
1
potential
1
biosafety
1
coronavirus
1
covid-19
1
specimens
1

References

(Supplied by CrossRef)

World Health Organization (WHO) et al.
2020

European Centre for Disease Prevention and Control ( et al.
2020

Similar Publications